Gilead reports ‘positive data’ on remdesivir coronavirus drug trial

CNBC ^ | 4/229/20 | Berkeley Lovelace Jr.

[LisaFab]

Gilead Sciences said Wednesday it is aware of “positive data” from one of its studies looking at antiviral drug remdesivir as a potential treatment for the coronavirus.

[magna carta]

For cash pay patients it is much more costly than the HCQ option..

[nuconvert]

Can’t believe what Gilead is saying.
Better to wait until independent study results are done.

[LisaFab]

Supposedly the study was done by the national institute of allergy and infectious diseases.

[AU72]

Of course they would, it’s their product.

[AU72]

Meanwhile ‘crickets’ out of NY of the results of the HDC testing.

[Missouri gal]

Professor Didier Raoult of the French HCQ studies says his informal information about remdesivir is that 60% of patients who receive it had side effects. He didn't state what those side effects were. Just sayin’.

[nuconvert]

It says,

“The company also said another trial by the National Institute of Allergy and Infectious Diseases met its main goal. It did not provide further details, however. “

“another trial”....What trial study is this report of findings coming from?

“The clinical trial involved 397 patients with severe cases of Covid-19. The severe study is “single-arm,” meaning it did not evaluate the drug against a control group of patients who didn’t receive the drug.”

That’s a small group & no control group. 50% improved...I don’t know, this study & the results sound murky to me.

[LisaFab]

All I know is that Fox Business is touting the NIAID report for the 450+ rise in the Dow this morning.

[RBW in PA]

Forget about “HCQ”, your masters have already selected this company and product as the preferred choice. Follow the money.

[faucetman]

I just read somewhere that the first trials of this were a total FAILURE!

[Presbyterian Reporter]

Keep in mind this message comes to you from the ‘pump and dump’ puppets at CNBC who are obliged to make their Brokerage Firm masters happy.

Gilead went from $60 to $85 based upon the hyoe from CNBC and the Brokerage Firms.

[nuconvert]

Yeah, I saw that too.

[ProtectOurFreedom]

"Another" trial can be interpreted two ways...
1. They conducted a second trial at the same place by the same organization. As in "Those initial results weren't good. Let's do another trial."
2. The trials were conducted by two different organizations at different times and places. As in "Org A conducted a trial and Org B conducted another trial."

another: adjective
1. being one more or more of the same; further; additional: "another piece of cake."
2. different; distinct; of a different period, place, or kind: "at another time; another man."

Is that intentionally vague and confusing by Gilead?

[ProtectOurFreedom]

Amazing turn-around! Just six days ago, the news everywhere was “remdesivir” FLOPPED! It’s NO GOOD.

Today it’s our new wonder drug savior.

Did the MSM get a new memo?

[nuconvert]

Or it may just be poorly written